 |
 |
|
 |
 |
Comments on Related Papers |
 |
  |
| |
Related Paper: Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles.
Comment by: Hiroshi Mori, ARF Advisor
|
 |
 |
Permalink |
 |
 |
A view is provided in living cells with and without exogenously transfected tau. It is interesting to see a mechanism for how kinesin attachs or detachs on microtubules with the aid of tau. View all comments by Hiroshi Mori
|
 |

|
| |
Related Paper: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.
Comment by: Peter Davies
|
 |
 |
Permalink |
 |
 |
I recommend this paper
"This paper continues the Mandelkow's fine work trying to unravel the mechanism of PHF formation by in vitro studies of structural changes that occur in tau on aggregation. Their identification of regions of tau that seem to be important for aggregation through beta-sheet formation is probably relevant to the mechanism of PHF formation in AD. They are the only group (to my knowledge) to be able to show formation of true paired helical filament structures using mutant tau constructs. Although this is a rather esoteric point, there is some debate about whether neuronal death in the tau mutation cases involves PHF formation as a necessary step. In one of the mutations they use in their study, P301L, the human disease does not appear to involve extensive PHF formation.
The Mandelkows discuss the possible mechanisms of cell death in tau mutation cases at some length, and it is clear that in most cases, more than one mechanism might participate in killing cells. However, these mechanistic studies point to important hypotheses that can be tested in cellular and perhaps animal models....
Read more
"This paper continues the Mandelkow's fine work trying to unravel the mechanism of PHF formation by in vitro studies of structural changes that occur in tau on aggregation. Their identification of regions of tau that seem to be important for aggregation through beta-sheet formation is probably relevant to the mechanism of PHF formation in AD. They are the only group (to my knowledge) to be able to show formation of true paired helical filament structures using mutant tau constructs. Although this is a rather esoteric point, there is some debate about whether neuronal death in the tau mutation cases involves PHF formation as a necessary step. In one of the mutations they use in their study, P301L, the human disease does not appear to involve extensive PHF formation.
The Mandelkows discuss the possible mechanisms of cell death in tau mutation cases at some length, and it is clear that in most cases, more than one mechanism might participate in killing cells. However, these mechanistic studies point to important hypotheses that can be tested in cellular and perhaps animal models. For example, it will be very interesting to see if transgenic mice with the deletion of lysine at position 280 would show early and extensive PHF formation, as this in vitro work clearly suggests. No doubt attempts to make these mice are already underway." -- Peter Davies, Albert Einstein College of Medicine, Bronx, New York.
‑ Peter Davies View all comments by Peter Davies
|
 |
 |
| |
Submit a Comment on this Paper |
 |
 |
 |
 |
| |
 |
 |
| |
REAGENTS/MATERIAL:
Studied neuron-like cell models (N2a neuroblastoma), cultured primary cortical neurons from rats or mice, and chicken retinal ganglion cells (RGCs) for the effects of tau overexpression. An N2a neuroblastoma cell line stably transfected with APP695 was provided by Drs. G. Thinakaran and S. Sisodia (University of Chicago, Chicago, IL).
Antibodies used in this study were rat monoclonal anti-tubulin YL1 (serotec), mouse monoclonal antibody DM1A (Sigma-Aldrich), polyclonal rabbit anti-tau antibody K9JA (Dako), and polyclonal rabbit anti-PMP69 antibody for peroxisomes (gift from Dr. W. Just, University of Heidelberg, Heidelberg, Germany). The monoclonal mouse antibody SMI32 (Sternberger) was used for the detection of unphosphorylated neurofilaments. The monoclonal tag antibodies from mouse against HA tag (12CA5) and myc tag were obtained from Roche Diagnostics and Invitrogen. Polyclonal anti-APP B5 (5313), (residues 444–592) was a gift from Dr. C. Haass (University of München, München, Germany), and monoclonal antibody 6E10 was from Senetek (now produced by Signet).
|
|
|
 |